Diagnostics Pipeline: 2024 Trends in FDA Approvals
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
From - Diagnostic Testing & Emerging Technologies
Reanalysis of clinical exome data at a two- to three-year interval could result in an incremental 10 percent diagnostic yield…
From - Diagnostic Testing & Emerging Technologies
Patients increasingly prefer to receive laboratory test results via password-protected websites and portals, according to…
From - Diagnostic Testing & Emerging Technologies
Despite appealing the Centers for Medicare and Medicaid's (CMS) sanctions resulting from inspection of…
From - Diagnostic Testing & Emerging Technologies
Personalized medicine is driving the need for isolation of rarer target cell populations, including for the enrichment of…
From - Diagnostic Testing & Emerging Technologies
Experts say the next big advance in achieving a healthier weight will be to use an individual's genetic data to customize diets and…